Biotech

All Articles

Duality finds cash for ADC trials as IPO surge spreads to Asia

.China's Duality Biotherapeutics has actually submitted (PDF) documents for a Hong Kong IPO, finding...

YolTech markets China rights to genetics editing treatment for $29M

.Four months after Mandarin genetics editing and enhancing business YolTech Therapeutics took its ch...

Addex inventory increases after Indivior offers up to $300M for compound

.Indivior is picking up a tiny particle allosteric modulator tailored to alleviate substance usage p...

Molecular Partners modifies AML trial over 'suboptimal visibility'

.Molecular Partners has actually recognized "suboptimal direct exposure" to its tetra-specific T-cel...

Despite mixed market, a venture capital rebirth could be being available in Europe: PitchBook

.While the biotech assets scene in Europe has slowed quite following a COVID-19 financing boom in 20...

8 months after a $213M fundraise, gene publisher Volume makes cuts

.After rearing $213 million in 2023-- some of the year's largest private biotech shots-- Tome Biosci...

BioMarin develops exec staff along with biotech vets-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of substantial leadership hirings, shootings...

Biopharma Q2 VC reached highest degree given that '22, while M&ampA decreased

.Equity capital financing right into biopharma rose to $9.2 billion across 215 deals in the second f...

Bicara, Zenas seek IPOs to drive late-phase possessions toward market

.Bicara Therapeutics and also Zenas Biopharma have actually supplied new incentive to the IPO market...

Genentech to finalize cancer immunology study team

.Genentech will definitely shut its cancer immunology study team, and unit mind and also popular cel...